The perfect AI stock under $10

Wealthiest Investor News

Dear Reader,

If you're looking for a great AI stock under $10... you need to 
read this right away.

What the company is doing is pretty incredible. It could end up saving billions of lives... and billions of dollars.

In short, the company is 
the creator of the first AI-designed drug to enter clinical trials.

And this is a huge deal.

Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion.

However, new AI technology has the potential to make the process up to 1000 times faster.

The Wall Street Journal reports that "the time required for the early stages of drug discovery could shrink from years to months."

Not only that, it has the potential to develop "never-before-seen molecules that could treat diseases like pancreatic cancer or ALS."

In short, this is groundbreaking stuff.

And 
this #1 AI company is at the forefront of all of it.

The biggest pharmaceutical companies in the world are lining up to work with them.
For example...

  •        Merck is collaborating with them on three projects that could generate up to $674 million in revenue.

  •        French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs.

  •        Bristol Meyers Squibb signed a $1.2 billion partnership with the company.

And yet... the company I'm talking about is valued at just over $500 million today. And it trades for less than $10.

In other words, these deals have the potential to drive the stock many times higher in the months and years ahead.

So again, if you're looking for a great AI stock to own, you need to 
watch this presentation right away.


Sincerely,

Rachel Gearhart
Publisher, The Oxford Club

P.S. The best way to play this AI stock involves an investment strategy used by a Kansas welder to become one of the wealthiest people in the world.

See his incredible investment approach here.

Advertising Disclosure: This email contains paid advertisements.

Legal Entity Information: Wealthiest Investor News is a website owned and operated by Darwin Investor Network, which is a DBA of The Darwin Agency, Inc.

The above is a paid advertisement. If you do not want to receive emails from us, you can follow this link to unsubscribe. and you will be removed from future mailings.

Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here.

This Email is From Our Associates At Oxford Club

You are receiving this e-mail at punjabsvera@gmail.com as a part of your free subscription to the

Wealthiest Investor News E-Letter.

If you can't see this message, view it in your browser.

To read our privacy policy follow this link.

If you do not want to receive emails from us, you can follow this link to unsubscribe. Or to unsubscribe by mail, write us at:

Wealthiest Investor News | 2319 N Andrews Avenue; Fort Lauderdale, FL 33311

Website: Wealthiest Investor News

Nothing in this email should be considered personalized financial advice. Staff members at Wealthiest Investor News are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice.

Copyright © 2023 Wealthiest Investor News. All rights reserved.

-

Post a Comment

Previous Post Next Post

Contact Form